
Once-Yearly Lenacapavir Looks Promising for HIV PrEP
Twice-yearly lenacapavir pre-exposure prophylaxis (PrEP), which is expected to launch this summer, has been hailed as a major breakthrough, but once-yearly HIV prevention shots could have an even bigger impact on the epidemic. Gilead Sciences revealed in …